BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
FGF21
,
Apoptosis
,
Inflammatory disorder
,
Lung
,
Pharmacogenetics
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD-467
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Global Burden of Disease 2017 estimates for Major Depressive Disorder: a critical appraisal of the e…
Evaluation of several oximes as reactivators of unaged soman-inhibited whole blood acetylcholinester…
Determination of the oximes 2-hydroxyiminomethyl-3-methyl-1-[2-(3-methyl- 3-nitrobutyloxymethyl)]imi…
High-performance liquid chromatographic analysis of imidazolium and pyridinium oximes in plasma and …
Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinestera…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants a…
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Seve…
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Participants With Moderately to Sever…
A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Y…
A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Activ…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ